Company intelligence / Profile preview

RBL LLC

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

RBL LLC is a biotech venture creation studio rapidly building clinical-stage companies based on breakthrough medical technologies from Rice University. Its first spin-out, Sentinel BioTherapeutics, is advancing a localized cytokine immunotherapy platform in Phase 1 clinical development for solid tumors, with early biomarker data demonstrating dose-dependent increases in checkpoint expression, supporting rationale for combination with checkpoint inhibitors[4].

Therapeutic areas: Oncology
Modalities: Cell therapyDrug deliveryEngineered therapeutic
Industry: Investors

Partnerships

Rice University Biotech Launch PadTexas Medical CenterModi VenturesCarnrite Ventures

Beyond the preview

Go deeper on RBL LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RBL LLC.

Explore the full profile